REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $885 | -68.1% | 77,200 | -10.4% | 0.00% | -75.0% |
Q1 2023 | $2,775 | -98.2% | 86,155 | +676.2% | 0.00% | – |
Q2 2022 | $153,000 | -52.6% | 11,099 | -33.1% | 0.00% | – |
Q1 2022 | $323,000 | -20.8% | 16,583 | -33.8% | 0.00% | – |
Q4 2021 | $408,000 | +2300.0% | 25,048 | +4131.1% | 0.00% | – |
Q2 2021 | $17,000 | -94.7% | 592 | -94.8% | 0.00% | – |
Q1 2021 | $320,000 | -29.8% | 11,456 | -28.9% | 0.00% | -100.0% |
Q4 2020 | $456,000 | – | 16,118 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |